EFFICACY OF LIVE ORAL TYPHOID VACCINE (SALMONELLA-TYPHI TY-21A) IN VOLUNTEER STUDIES AND FIELD TRIALS

被引：0
|
作者：
CRYZ, SJ
FURER, E
LEVINE, MM
机构：
[1] SCHWEIZER SERUM & IMPFINST,POSTFACH 2707,CH-3001 BERN,SWITZERLAND
[2] UNIV MARYLAND,SCH MED,CTR VACCINE DEV,BALTIMORE,MD 21201
来源：
SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT | 1988年 / 118卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：467 / 470
页数：4
相关论文
共 50 条
  • [21] COMPLIANCE WITH LIVE, ORAL TY21A TYPHOID VACCINE
    KAPLAN, DT
    HILL, DR
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 267 (08): : 1074 - 1074
  • [22] DEMONSTRATION OF SPECIFIC IGA IN HUMAN FECES AFTER IMMUNIZATION WITH LIVE TY21A SALMONELLA-TYPHI VACCINE
    CANCELLIERI, V
    FARA, GM
    JOURNAL OF INFECTIOUS DISEASES, 1985, 151 (03): : 482 - 484
  • [23] IMMUNOGENICITY OF THE LIVE ORAL TYPHOID VACCINE TY21A
    BARTHOLOMEUSZ, RCA
    JOHNSON, M
    LABROOY, JT
    SHEARMAN, DJC
    ROWLEY, D
    GASTROENTEROLOGY, 1985, 88 (05) : 1317 - 1317
  • [24] IDENTIFICATION OF SALMONELLA-TYPHI BY PCR AMONG RECIPIENTS OF ORAL TYPHOID VACCINE LOTS
    ARYA, SC
    JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (04) : 1133 - 1133
  • [25] INTRODUCTION OF SHIGELLA-FLEXNERI 2A-TYPE AND GROUP ANTIGEN GENES INTO ORAL TYPHOID VACCINE STRAIN SALMONELLA-TYPHI TY21A
    BARON, LS
    KOPECKO, DJ
    FORMAL, SB
    SEID, R
    GUERRY, P
    POWELL, C
    INFECTION AND IMMUNITY, 1987, 55 (11) : 2797 - 2801
  • [26] SAFETY AND IMMUNOGENICITY OF SALMONELLA-TYPHI TY21A VACCINE IN YOUNG THAI CHILDREN
    CRYZ, SJ
    VANPRAPAR, N
    THISYAKORN, U
    OLANRATMANEE, T
    LOSONSKY, G
    LEVINE, MM
    CHEARSKUL, S
    INFECTION AND IMMUNITY, 1993, 61 (03) : 1149 - 1151
  • [27] SAFETY, IMMUNOGENICITY, AND EFFICACY AGAINST CHOLERA CHALLENGE IN HUMANS OF A TYPHOID-CHOLERA HYBRID VACCINE DERIVED FROM SALMONELLA-TYPHI TY21A
    TACKET, CO
    FORREST, B
    MORONA, R
    ATTRIDGE, SR
    LABROOY, J
    TALL, BD
    REYMANN, M
    ROWLEY, D
    LEVINE, MM
    INFECTION AND IMMUNITY, 1990, 58 (06) : 1620 - 1627
  • [28] EFFICACY OF ONE OR 2 DOSES OF TY21A SALMONELLA-TYPHI VACCINE IN ENTERIC-COATED CAPSULES IN A CONTROLLED FIELD TRIAL
    BLACK, RE
    LEVINE, MM
    FERRECCIO, C
    CLEMENTS, ML
    LANATA, C
    ROONEY, J
    GERMANIER, R
    VACCINE, 1990, 8 (01) : 81 - 84
  • [29] LACK OF IMMUNE-RESPONSE TO THE VI COMPONENT OF A VI-POSITIVE VARIANT OF THE SALMONELLA-TYPHI LIVE ORAL VACCINE STRAIN TY21A IN HUMAN STUDIES
    TACKET, CO
    LOSONSKY, G
    TAYLOR, DN
    BARON, LS
    KOPECKO, D
    CRYZ, S
    LEVINE, MM
    JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (04): : 901 - 904
  • [30] EFFICACY OF FUTURE FORMULATIONS OF TY21A SALMONELLA-TYPHI VACCINES IN ENDEMIC AREAS
    ARYA, SC
    VACCINE, 1990, 8 (06) : 612 - 612
12345